K. Conard

Derivation of human embryonic stem cells in defined conditions

J. Thomson, Jeffrey M. Jones, T. Ludwig, 2006, Nature Biotechnology.

Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children

D. Amaral, R. Burrier, B. Corbett, 2014, PloS one.

Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.

R. Burrier, Laura A. Egnash, K. Conard, 2013, Birth defects research. Part B, Developmental and reproductive toxicology.

Secreted Proteoglycans Directly Mediate Human Embryonic Stem Cell‐Basic Fibroblast Growth Factor 2 Interactions Critical for Proliferation

Lloyd M. Smith, Ryan J. Wagner, J. Thomson, 2008, Stem cells.

Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells

J. Brumbaugh, J. Thomson, G. McAlister, 2008, Proceedings of the National Academy of Sciences.

Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics.

D J Dix, D. Dix, T. Knudsen, 2011, Toxicology and applied pharmacology.

Metabolic biomarkers of prenatal alcohol exposure in human embryonic stem cell-derived neural lineages.

K. Conard, P. West, J. Palmer, 2012, Alcoholism, clinical and experimental research.